TY  - GEN
AU  - McMeekin,D Scott
AU  - Sill,Michael W
AU  - Darcy,Kathleen M
AU  - Abulafia,Ovadia
AU  - Hanjani,Parviz
AU  - Pearl,Michael L
AU  - Rubin,Stephen C
AU  - Rose,Peter G
AU  - Small,Laurie
AU  - Benbrook,Doris Mangiaracina
TI  - A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: a Gynecologic Oncology Group study
SN  - 1095-6859
PY  - 2013///0207
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Angiogenesis Inhibitors
KW  - therapeutic use
KW  - Angiogenic Proteins
KW  - blood
KW  - Biomarkers, Tumor
KW  - Carcinosarcoma
KW  - Drug Administration Schedule
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Female
KW  - Humans
KW  - Middle Aged
KW  - Survival Analysis
KW  - Thalidomide
KW  - Treatment Outcome
KW  - Uterine Neoplasms
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1016/j.ygyno.2012.07.095
ER  -